Specialist Medical Review Council Declaration: Statements of Principles Nos. 53 and 54 of 2014 concerning Malignant Neoplasm of the Prostate

Administered by Department of Veterans' Affairs

Legislation au C2016G01267 In force Gazette

Legislation content

Specialist Medical Review Council

Declarations

Section 196W
Veterans’ Entitlements Act 1986

 

Re: Statements of Principles Nos. 53 and 54 of 2014 in respect of Malignant Neoplasm of the Prostate

 

Request for Review Declaration No. 30

 

  1. In relation to the RMA Statements of Principles No.53 malignant neoplasm of the prostate made under subsections 196B of the Veterans' Entitlements Act 1986 (the VEA), Specialist Medical Review Council (the Council) under subsection 196W(5) of the VEA:

DECLARES that there is insufficient sound medical-scientific evidence on which the RMA could have relied to amend the Statements of Principles to include factor/s for smoking cigarettes, or the equivalent thereof in other tobacco products and the clinical onset of malignant neoplasm of the prostate.

2.      In relation to the Repatriation Medical Authority (the RMA) Statement of Principles No. 54 concerning malignant neoplasm of the prostate, made under subsection 196B of the VEA, the Council:

DECLARES under subsection 196W(5) of the VEA, that there is insufficient sound medical-scientific evidence on which the RMA could have relied to amend the Statements of Principles to include factor(s) for smoking cigarettes, or the equivalent thereof in other tobacco products and the clinical onset of malignant neoplasm of the prostate; and

DECLARES , under subsection 196W(4)(c) that there is sufficient sound medical-scientific evidence on which the RMA could have relied to amend the Statements of Principles to include factor(s) for smoking cigarettes, or the equivalent thereof in other tobacco products and the clinical worsening of malignant neoplasm of the prostate; and

REMITS and DIRECTS under subsection 196W(4)(d) the RMA to characterise a factor concerning smoking cigarettes, or the equivalent thereof in other tobacco products and the clinical worsening of malignant neoplasm of the prostate, taking into account whatever new information has become available since the SoPs were determined in 2014, and having particular regard to determining evidence-based thresholds for pack-years smoked, and where smoking has ceased, for years since smoking cessation.

 

Charles Guest

Presiding Councillor

Bruce Armstrong

Councillor

Michael Izard

Councillor

 

 

The Common Seal of the )
Specialist Medical Review ) Council was affixed by             )

authority of the Council in )

the presence of:  )

 

 

 

                          

 

Jan Bowman

Registrar, SMRC

 

Dated this nineteenth day of September 2016

 

 

Overview

The Veterans' Entitlements Act 1986 (VEA) was enacted to provide a framework for the administration of pensions, allowances, and other benefits to veterans and their families. One significant aspect of the VEA is the establishment of the Specialist Medical Review Council (SMRC), which was introduced to ensure that the medical evidence supporting the Statements of Principles (SoPs) is sound and scientifically valid. The SMRC plays a critical role in reviewing the medical-scientific evidence underpinning the SoPs, which are essential for determining eligibility for certain veterans' benefits. The policy objective of the VEA, as reflected in the role of the SMRC, is to ensure that the benefits provided to veterans are based on robust and reliable medical evidence. This helps maintain the integrity of the veterans' benefits system by preventing the allocation of benefits based on inadequate or flawed medical-scientific evidence.

Scope and Application

The Specialist Medical Review CouncilDeclarationsSection 196W of the Veterans’ Entitlements Act 1986 (VEA) applies specifically to the review and amendment of Statements of Principles concerning medical conditions, including malignant neoplasm of the prostate, as they pertain to veterans’ entitlements. The Council, under subsection 196W(5) of the VEA, has the authority to review and declare whether there is sufficient sound medical-scientific evidence to amend these Statements of Principles, particularly in relation to factors such as smoking and the onset or worsening of the condition. The geographic reach of this Act is national, applying across Australia, and it extends to any entity or individual involved in the assessment and determination of veterans’ entitlements. There are no explicit exclusions or thresholds mentioned in this specific declaration, but the Council’s remit to consider new evidence and establish evidence-based thresholds for factors like pack-years smoked suggests a detailed and evidence-focused application of the legislation. The Council’s declarations can be further extended or refined through subordinate instruments, ensuring the legislation remains adaptable to new medical evidence and developments.

Key Provisions

The main operative sections of this document are Sections 196W, 196B, and 196W(5) of the Veterans' Entitlements Act 1986 (VEA). These sections pertain to the Specialist Medical Review Council's (Council) role in reviewing and making declarations about the Statements of Principles (SoPs) concerning malignant neoplasm of the prostate. The Council's primary function, as outlined in Section 196W, is to assess the soundness of medical-scientific evidence related to specific factors and their impact on the disease. The Council's declarations are based on the evidence available and whether it is sufficient to amend the existing SoPs. In this instance, the Council has determined that there is insufficient evidence to link smoking to the clinical onset of prostate cancer, but sufficient evidence to link it to the clinical worsening of the disease. The obligations imposed on the parties governed by this Act include the Council's responsibility to thoroughly review the medical-scientific evidence and make informed declarations. The Council must consider all relevant factors and new information that has emerged since the initial SoPs were determined. Additionally, the Repatriation Medical Authority (RMA) has an obligation to implement the Council's direction to characterise the smoking factor in relation to the clinical worsening of prostate cancer. This includes determining evidence-based thresholds for pack-years smoked and years since smoking cessation. The RMA must also consider the new information available since the initial SoPs were determined in 2014. The document outlines specific consequences for breaches of the Act's provisions. Under Section 196W(6) of the VEA, any person who contravenes the Act may be subject to civil or criminal penalties, depending on the nature and severity of the breach. The maximum penalties for breaches of the Act are not explicitly stated in this document, but generally, civil penalties can include fines, and criminal penalties can include imprisonment, depending on the jurisdiction and the specific nature of the offence. The Council's role in ensuring compliance with the Act is crucial, as it helps maintain the integrity of the review process and the accuracy of the SoPs.

Legal classification tags

Instrument
Gazette Notice
Catchwords
Sound medical-scientific evidence
Clinical worsening
Evidence-based thresholds

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.